These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28028501)

  • 21. Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection.
    Lee CN; Chiu LH; Fang CL; Yeh SD; Zuo CS; Chen SC; Kuo LK; Wang YM; Lai WT
    J Vis Exp; 2020 Feb; (156):. PubMed ID: 32116301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic single-walled carbon nanotubes as efficient drug delivery nanocarriers in breast cancer murine model: noninvasive monitoring using diffusion-weighted magnetic resonance imaging as sensitive imaging biomarker.
    Al Faraj A; Shaik AP; Shaik AS
    Int J Nanomedicine; 2015; 10():157-68. PubMed ID: 25565811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic Endoglin Aptamer Nanoprobe for Targeted Diagnosis of Solid Tumor.
    Zhong L; Zou H; Huang Y; Gong W; He J; Tan J; Lai Z; Li Y; Zhou C; Zhang G; Li G; Yang N; Zhao Y
    J Biomed Nanotechnol; 2019 Feb; 15(2):352-362. PubMed ID: 30596557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic targeting combined with active targeting of dual-ligand iron oxide nanoprobes to promote the penetration depth in tumors for effective magnetic resonance imaging and hyperthermia.
    Chen L; Wu Y; Wu H; Li J; Xie J; Zang F; Ma M; Gu N; Zhang Y
    Acta Biomater; 2019 Sep; 96():491-504. PubMed ID: 31302299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and characterization of Bombesin-superparamagnetic iron oxide nanoparticles as a targeted contrast agent for imaging of breast cancer using MRI.
    Jafari A; Salouti M; Shayesteh SF; Heidari Z; Rajabi AB; Boustani K; Nahardani A
    Nanotechnology; 2015 Feb; 26(7):075101. PubMed ID: 25642737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3.0-Tesla magnetic resonance scanner.
    Li X; Du X; Huo T; Liu X; Zhang S; Yuan F
    Acta Radiol; 2009 Jul; 50(6):583-94. PubMed ID: 19449236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo targeting imaging of pancreatic cancer using a Fe3O4@SiO2 nanoprobe modified with anti-mesothelin antibody.
    Liu F; Le W; Mei T; Wang T; Chen L; Lei Y; Cui S; Chen B; Cui Z; Shao C
    Int J Nanomedicine; 2016; 11():2195-207. PubMed ID: 27274243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High F-Content Perfluoropolyether-Based Nanoparticles for Targeted Detection of Breast Cancer by
    Zhang C; Moonshi SS; Wang W; Ta HT; Han Y; Han FY; Peng H; Král P; Rolfe BE; Gooding JJ; Gaus K; Whittaker AK
    ACS Nano; 2018 Sep; 12(9):9162-9176. PubMed ID: 30118590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
    Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
    Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring a new SPION-based MRI contrast agent with excellent water-dispersibility, high specificity to cancer cells and strong MR imaging efficacy.
    Ma X; Gong A; Chen B; Zheng J; Chen T; Shen Z; Wu A
    Colloids Surf B Biointerfaces; 2015 Feb; 126():44-9. PubMed ID: 25543982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A graphene quantum dot@Fe
    Su X; Chan C; Shi J; Tsang MK; Pan Y; Cheng C; Gerile O; Yang M
    Biosens Bioelectron; 2017 Jun; 92():489-495. PubMed ID: 27839733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bevacizumab and near infrared probe conjugated iron oxide nanoparticles for vascular endothelial growth factor targeted MR and optical imaging.
    Lin R; Huang J; Wang L; Li Y; Lipowska M; Wu H; Yang J; Mao H
    Biomater Sci; 2018 May; 6(6):1517-1525. PubMed ID: 29652061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of a multifunctional nanoprobe for tumor-targeted time-gated luminescence and magnetic resonance imaging in vitro and in vivo.
    Dai Z; Ma H; Tian L; Song B; Tan M; Zheng X; Yuan J
    Nanoscale; 2018 Jun; 10(24):11597-11603. PubMed ID: 29892761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preliminary study of breast cancer magnetic resonance targeting diagnosis basing on magnetic nanoparticles in vitro].
    Luo XF; Wu JT; Qu QX; Hu XH; Chen MX; Chen WX; Dong Y; Jiang L
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(35):2830-3. PubMed ID: 24360184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic Separation-Assistant Fluorescence Resonance Energy Transfer Inhibition for Highly Sensitive Probing of Nucleolin.
    Li YR; Liu Q; Hong Z; Wang HF
    Anal Chem; 2015 Dec; 87(24):12183-9. PubMed ID: 26558409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Folic acid-conjugated superparamagnetic iron oxide nanoparticles for tumor-targeting MR imaging.
    Li L; Gao F; Jiang W; Wu X; Cai Y; Tang J; Gao X; Gao F
    Drug Deliv; 2016 Jun; 23(5):1726-33. PubMed ID: 25715808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.
    Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M
    Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitive angiogenesis imaging of orthotopic bladder tumors in mice using a selective magnetic resonance imaging contrast agent containing VEGF121/rGel.
    Cho EJ; Yang J; Mohamedali KA; Lim EK; Kim EJ; Farhangfar CJ; Suh JS; Haam S; Rosenblum MG; Huh YM
    Invest Radiol; 2011 Jul; 46(7):441-9. PubMed ID: 21512397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gold-coated iron oxide nanoparticles as a T2 contrast agent in magnetic resonance imaging.
    Ahmad T; Bae H; Rhee I; Chang Y; Jin SU; Hong S
    J Nanosci Nanotechnol; 2012 Jul; 12(7):5132-7. PubMed ID: 22966533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting T1 and T2 dual modality enhanced magnetic resonance imaging of tumor vascular endothelial cells based on peptides-conjugated manganese ferrite nanomicelles.
    Gong M; Yang H; Zhang S; Yang Y; Zhang D; Li Z; Zou L
    Int J Nanomedicine; 2016; 11():4051-63. PubMed ID: 27578974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.